Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | President, R&D | March 03, 2026 | March 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date March 03, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $26.58 · Expires 2031-03-03 | Direct | 259,844 |
Reported balance
After 2026-03-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-03 · Grant · Acquired 259,844 · Balance 259,844 F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2026 Filed Mar 5, 2026 22:26 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 259,844 | $0.00 Strike: $26.58 | $0.00 |
DisclosureSEC source: 0001225208-26-003316 · doc4.xml · derivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,844 Underlying: Common Stock · 259,844 shares Expires 2031-03-03 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 23:33 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 6,833 | $27.09 | $185,105.97 |
DisclosureSEC source: 0001225208-26-002815 · doc4.xml · nonDerivative · entry 2 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,379 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 23:33 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 13,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002815 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,212 F1 · shares: The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon). Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 20:41 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 816 | $27.06 | $22,080.96 |
DisclosureSEC source: 0001225208-26-002482 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,829 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 22:55 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 12,887 | $26.44 | $340,732.28 |
DisclosureSEC source: 0001225208-26-001126 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,645 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 18:47 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 495,765 | $0.00 Strike: $25.75 | $0.00 |
DisclosureSEC source: 0001225208-25-003063 · doc4.xml · derivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495,765 Underlying: Common Stock · 495,765 shares Expires 2030-03-04 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:39 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 8,909 | $26.10 | $232,524.90 |
DisclosureSEC source: 0001225208-25-002709 · doc4.xml · nonDerivative · entry 2 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,238 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:39 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 17,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002709 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,147 F1 · shares: The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 17:41 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,872 | $26.42 | $128,718.24 |
DisclosureSEC source: 0001225208-25-002612 · doc4.xml · nonDerivative · entry 2 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,100 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 17:41 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 9,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002612 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,972 F1 · shares: The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2025 Filed Mar 3, 2025 22:31 UTC Amendment | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 403 | $26.65 | $10,739.95 |
DisclosureSEC source: 0001225208-25-002701 · doc4a.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,882 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 23, 2025 Filed Feb 25, 2025 23:58 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 662 | $26.30 | $17,410.60 |
DisclosureSEC source: 0001225208-25-002397 · doc4.xml · nonDerivative · entry 4 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,285 F6 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). F3 · price: Price is the closing price of Pfizer common stock on February 21, 2025. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:58 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 8,741 | $0.00 Strike: $30.17 | $0.00 |
DisclosureSEC source: 0001225208-25-002397 · doc4.xml · derivative · entry 6 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,741 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:58 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 7,798 | $26.08 | $203,371.84 |
DisclosureSEC source: 0001225208-25-002397 · doc4.xml · nonDerivative · entry 3 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,947 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:58 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 340 | $26.30 | $8,942.00 |
DisclosureSEC source: 0001225208-25-002397 · doc4.xml · nonDerivative · entry 2 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,745 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 21, 2025. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:58 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 8,741 | $30.17 | $263,715.97 |
DisclosureSEC source: 0001225208-25-002397 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 18:04 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 12,038 | $26.52 | $319,247.76 |
DisclosureSEC source: 0001225208-25-001142 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,344 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 18:28 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,150 | $27.04 | $112,216.00 |
DisclosureSEC source: 0001225208-24-003340 · doc4.xml · nonDerivative · entry 2 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,007 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 18:28 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 11,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003340 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,157 F1 · shares: The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 22:00 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 142,400 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001225208-24-003206 · doc4.xml · derivative · entry 2 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,400 Underlying: Common Stock · 142,400 shares Expires 2031-02-27 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 22:00 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 161,160 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001225208-24-003206 · doc4.xml · derivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,160 Underlying: Common Stock · 161,160 shares Expires 2029-02-27 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:44 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,794 | $27.76 | $133,081.44 |
DisclosureSEC source: 0001225208-24-003047 · doc4.xml · nonDerivative · entry 8 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,647 F8 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon). F6 · price: Price is the closing price of Pfizer common stock on February 23, 2024. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:44 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,403 | $27.76 | $38,947.28 |
DisclosureSEC source: 0001225208-24-003047 · doc4.xml · nonDerivative · entry 7 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,441 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). F6 · price: Price is the closing price of Pfizer common stock on February 23, 2024. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:44 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 15,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003047 · doc4.xml · nonDerivative · entry 6 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,844 F7 · shares: The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2024 Filed Feb 27, 2024 18:44 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 300 | $27.76 | $8,328.00 |
DisclosureSEC source: 0001225208-24-003047 · doc4.xml · nonDerivative · entry 5 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,389 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). F6 · price: Price is the closing price of Pfizer common stock on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:44 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 9,752 | $0.00 Strike: $27.34 | $0.00 |
DisclosureSEC source: 0001225208-24-003047 · doc4.xml · derivative · entry 10 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,752 shares Expires 2024-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:44 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 7,881 | $27.37 | $215,702.97 |
DisclosureSEC source: 0001225208-24-003047 · doc4.xml · nonDerivative · entry 4 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,689 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:44 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 675 | $27.76 | $18,738.00 |
DisclosureSEC source: 0001225208-24-003047 · doc4.xml · nonDerivative · entry 3 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,570 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:44 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 458 | $27.76 | $12,714.08 |
DisclosureSEC source: 0001225208-24-003047 · doc4.xml · nonDerivative · entry 2 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,245 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:44 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 9,752 | $27.34 | $266,619.68 |
DisclosureSEC source: 0001225208-24-003047 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| December 29, 2023 Filed Dec 29, 2023 23:05 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 34,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-011363 · doc4.xml · nonDerivative · entry 1 BOSHOFF CHRISTOFFEL · CIK 0001988687 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,296 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.